OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$9.99
-0.15 (-1.48%)
Open$10.15
Previous Close$10.14
Day High$10.26
Day Low$9.90
52W High$16.44
52W Low$6.23
Volume—
Avg Volume2.34M
Market Cap2.23B
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+467.6% upside
Current
$9.99
$9.99
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.09M | 59.91M | 384.00M |
| Net Income | -307,533,591 | -275,952,374 | 56.73M |
| Profit Margin | -511.9% | -486.3% | 14.8% |
| EBITDA | -307,252,106 | -291,016,451 | 95.97M |
| Free Cash Flow | — | — | 61.23M |
| Rev Growth | +0.3% | +0.3% | -3.5% |
| Debt/Equity | 0.11 | 0.11 | 0.35 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |